Search Results - "Hamlett, Eric D"
-
1
Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer's disease
Published in Molecular neurodegeneration (10-06-2019)“…In order for Alzheimer's disease (AD) to manifest, cells must communicate "pathogenic material" such as proteins, signaling molecules, or genetic material to…”
Get full text
Journal Article -
2
Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease
Published in Molecular therapy (06-04-2022)“…Brain pericytes regulate cerebral blood flow, maintain the integrity of the blood-brain barrier (BBB), and facilitate the removal of amyloid β (Aβ), which is…”
Get full text
Journal Article -
3
RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome
Published in Glia (01-07-2020)“…Inflammation can be resolved by pro‐homeostatic lipids called specialized pro‐resolving mediators (SPMs) upon activation of their receptors. Dysfunctional…”
Get full text
Journal Article -
4
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Published in Alzheimer's & dementia (01-05-2017)“…Abstract Introduction Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) neuropathology and dementia early in life. Blood biomarkers of AD…”
Get full text
Journal Article -
5
Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome
Published in Neurobiology of disease (01-02-2020)“…The pontine nucleus locus coeruleus (LC) is the primary source of noradrenergic (NE) projections to the brain and is important for working memory, attention,…”
Get full text
Journal Article -
6
Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
Published in Current Alzheimer research (01-01-2016)“…Down syndrome (DS) is the most common non-lethal genetic condition that affects approximately 1 in 700 births in the United States of America. DS is…”
Get more information
Journal Article -
7
Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain
Published in EBioMedicine (01-12-2021)“…Little is known about chronic cannabis smoking-associated oral microbiome and its effects on central nervous system (CNS) functions. In the current study, we…”
Get full text
Journal Article -
8
Unveiling the Intricate Link Between Anaerobe Niche and Alzheimer Disease Pathogenesis
Published in The Journal of infectious diseases (10-09-2024)“…Abstract Dysbiosis within microbiomes has been increasingly implicated in many systemic illnesses, such as cardiovascular disease, metabolic syndrome,…”
Get full text
Journal Article -
9
Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome
Published in Journal of Alzheimer's disease (01-01-2024)“…Down syndrome (DS) is one of the most commonly occurring chromosomal conditions. Most individuals with DS develop Alzheimer's disease (AD) by 50 years of age…”
Get more information
Journal Article -
10
p38 MAPK Is a Major Regulator of Amyloid Beta-Induced IL-6 Expression in Human Microglia
Published in Molecular neurobiology (01-09-2022)“…The accumulation of amyloid beta (Aβ) plaques in the brain is a hallmark of Alzheimer’s disease (AD) pathology. Microglial activation-mediated…”
Get full text
Journal Article -
11
Exosomal biomarkers in Down syndrome and Alzheimer's disease
Published in Free radical biology & medicine (01-01-2018)“…Every person with Down syndrome (DS) has the characteristic features of Alzheimer's disease (AD) neuropathology in their brain by the age of forty, and most go…”
Get full text
Journal Article -
12
The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
Published in Journal of clinical medicine (27-02-2024)“…: Individuals with Down syndrome (DS) exhibit an almost complete penetrance of Alzheimer's disease (AD) pathology but are underrepresented in clinical trials…”
Get full text
Journal Article -
13
Locus coeruleus and dorsal cingulate morphology contributions to slowed processing speed
Published in Neuropsychologia (28-01-2023)“…Slowed information processing speed is a defining feature of cognitive aging. Nucleus locus coeruleus (LC) and medial prefrontal regions are targets for…”
Get full text
Journal Article -
14
Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease
Published in Annals of neurology (01-06-2022)“…Objective The Alzheimer's continuum is biologically defined by beta‐amyloid deposition, which at the earliest stages is superimposed upon white matter…”
Get full text
Journal Article -
15
Neuropathological findings in Down syndrome, Alzheimer’s disease and control patients with and without SARS-COV-2: preliminary findings
Published in Acta neuropathologica (01-06-2024)“…The SARS-CoV-2 virus that led to COVID-19 is associated with significant and long-lasting neurologic symptoms in many patients, with an increased mortality…”
Get full text
Journal Article -
16
Alpha-lipoic acid supplementation protects enzymes from damage by nitrosative and oxidative stress
Published in Biochimica et biophysica acta (01-01-2016)“…S-nitrosylation of mitochondrial enzymes involved in energy transfer under nitrosative stress may result in ATP deficiency. We investigated whether α-lipoic…”
Get full text
Journal Article -
17
Exosome release and cargo in Down syndrome
Published in Developmental neurobiology (Hoboken, N.J.) (01-07-2019)“…Down syndrome (DS) is a multisystem disorder affecting 1 in 800 births worldwide. Advancing technology, medical treatment, and social intervention have…”
Get full text
Journal Article -
18
Down Syndrome Biobank Consortium: A perspective
Published in Alzheimer's & dementia (01-03-2024)“…Individuals with Down syndrome (DS) have a partial or complete trisomy of chromosome 21, resulting in an increased risk for early‐onset Alzheimer's disease…”
Get full text
Journal Article -
19
Designer receptors enhance memory in a mouse model of Down syndrome
Published in The Journal of neuroscience (28-01-2015)“…Designer receptors exclusively activated by designer drugs (DREADDs) are novel and powerful tools to investigate discrete neuronal populations in the brain. We…”
Get full text
Journal Article -
20
Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society
Published in Molecular syndromology (01-04-2023)“…Research focused on Down syndrome continued to gain momentum in the last several years and is advancing our understanding of how trisomy 21 (T21) modifies…”
Get full text
Journal Article